Hormone Therapy Safe After Ovarian Cancer (non-serous subtypes) Ovarian Cancer and Us OVARIAN CANCER and US Ovarian Cancer and Us

Blog Archives: Nov 2004 - present


Special items: Ovarian Cancer and Us blog best viewed in Firefox

Search This Blog

Wednesday, April 20, 2016

Hormone Therapy Safe After Ovarian Cancer (non-serous subtypes)

medical news research

 Although the study is limited by its retrospective design and small sample size, one of its strengths is its sole focus on nonserous epithelial ovarian cancer, "which is crucial because these histologies are linked to hormone stimulation and are associated with longer survival," the authors write. "These are the women who might benefit most from HT but who are also at highest theoretical risk of recurrence as a result of exposure to hormones. We found that these women may instead actually benefit from HT use."


Post a Comment

Your comments?